HIGHLIGHTS
- who: Adverse drug reaction and collaborators from the Postgraduate Education, Russia Shiraz University of Medical Sciences, Iran have published the paper: The pharmacogenetics of in a case series of antidepressant responses, in the Journal: (JOURNAL)
- what: Despite the discordance, both the wider literature and the study showed that approximately 73%-85% of patients with mental disorders carry non-NM phenotypes in CYP2D6 and/or CYP2C19. With this, the authors provide an insight into the clinical utility of CYP2D6 and CYP2C19 in antidepressant prescribing.
- future: 6 Future work and conclusion There are several suggestions . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.